President Donald Trump’s freeze on U.S. foreign aid has temporarily suspended key anti-narcotics programs in Mexico, impacting efforts to curb the flow of fentanyl into the U.S. The freeze affects all programs under the State Department’s Bureau of International Narcotics and Law Enforcement (INL), which trains Mexican authorities to dismantle clandestine fentanyl labs and intercept precursor chemicals.
INL initiatives, including drug-detecting canines that helped seize millions of fentanyl pills in 2023, have been put on hold. Former State Department official Dafna H. Rand criticized the freeze, stating it weakens the U.S.'s ability to combat the fentanyl crisis, which has claimed over 450,000 American lives in the past decade.
The freeze follows Trump’s "America First" policy, halting billions in foreign assistance worldwide. Despite Secretary of State Marco Rubio issuing waivers for humanitarian aid, most programs remain in limbo. Some officials suggest exemptions for foreign anti-narcotics programs are being considered, though no decision has been made on INL’s Mexico projects.
Trump has pledged to destroy Mexican cartels and threatened 25% tariffs on Mexico if it fails to curb fentanyl trafficking and illegal immigration. He has also pushed for designating cartels as terrorist organizations, expanding U.S. authority to target them. U.S. military surveillance of Mexican cartels has increased, raising concerns that Trump’s approach is shifting from cooperation with Mexico to unilateral action.
During his campaign, Trump called for military operations against cartels, signaling a tougher stance. While the administration’s next steps remain uncertain, the suspension of INL programs has stalled critical efforts to combat fentanyl at its source, complicating U.S.-Mexico cooperation on drug enforcement.


FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
States Sue Trump Administration Over SNAP Restrictions for Legal Immigrants
Bolsonaro Blames Medication Mix-Up for Ankle Monitor Tampering as Detention Continues
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean
Tunisian Opposition Figure Chaima Issa Arrested Amid Rising Crackdown
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
Appeals Court Blocks Expansion of Fast-Track Deportations in the U.S.
China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai
Bolsonaro Detained Over Alleged Escape Risk After Ankle Monitor Tampering 



